EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Investigation on platelet aggregation of dauricine in patients with cardiovascular diseases






Chinese Pharmacological Bulletin 10(1): 33-36

Investigation on platelet aggregation of dauricine in patients with cardiovascular diseases

Dauricine is a new antiarrhythmic compound isolated from Menispermum dauricum rhizomes. Dauricine markedly inhibited aggregation of human platelets induced by ADP and other substances in vitro in a dose-dependent manner. A 20-30% inhibition of platelet aggregation was achieved after oral administration of 300 mg dauricine, 3 times a day, for 21 days, to 22 patients with coronary heart disease.

(PDF 0-2 workdays service: $29.90)

Accession: 002416990



Related references

Effect of dauricine on platelet aggregation in rabbits. Xi'an Yike Daxue Xuebao 7(1): 31-34, 106-107, 1986

Effects of dauricine and daurisoline on platelet aggregation and adhesion. Journal of China Medical University 24(6): 579-581, 1995

The effect of ketanserin, a 5-HT2-receptor antagonist, on 5-hydroxytryptamine-induced irreversible platelet aggregation in patients with cardiovascular diseases. Agents and Actions 16(5): 313-317, 1985

Effect of dauricine on rat and human platelet aggregation and metabolism of arachidonic acid in washed rat platelets. Yao Xue Xue Bao 24(2): 85-88, 1989

The effect of ketanserin a 5 hydroxytryptamine 2 receptor antagonist on 5 hydroxytryptamine induced irreversible platelet aggregation in patients with cardiovascular diseases. Agents & Actions 16(5): 313-317, 1985

Prevention of cardiovascular diseases by inhibitors of platelet aggregation. Revue Medicale de Bruxelles 3(6): 415-424, 1982

Role of Platelet-Monocyte Aggregation in the Onset of Acute Cardiovascular and Cerebrovascular Diseases. World Science and Technology 13(3), 2011

Defective platelet aggregation and increased platelet turnover in patients with myelofibrosis and other myeloproliferative diseases. Scandinavian Journal of Haematology 26(4): 339-344, 1981

Factor viii associated antigen platelet retention and platelet aggregation in patients with vascular diseases. Thrombosis & Haemostasis 38(1): 336, 1977

Platelet aggregation in several cardiovascular diseases determined with a modified screen filtration pressure method. Journal of Medicine 1(3): 132-141, 1970